000 02168nam  2200385zi 4500
0019.931311
003CaOODSP
00520240201105620
006m     o  d f      
007cr mn|||||||||
008231211t20242023onc     ob   f000 0 eng d
020 |a9780660692654|q(report)
020 |a9780660692661|q(summary)
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP5-176/1-2024E-PDF
0861 |aHP5-176/2-2024E-PDF
24500|aGuidance on an additional dose of COVID-19 vaccines in the spring of 2024 for individuals at high risk of severe illness due to COVID-19.
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cJanuary 12, 2024.
264 4|c©2023
300 |a1 online resource (13 unnumbered pages) + |e1 summary (5 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |aIssued also in French under title: Directives sur l'administration d'une dose supplémentaire de vaccins contre la COVID-19 au printemps 2024 pour les personnes exposées à un risque élevé de maladie sévère en raison de la COVID-19.
500 |aAt head of title: "An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)."
504 |aIncludes bibliographical references.
650 0|aCOVID-19 (Disease)|xVaccination|xGovernment policy|zCanada.
650 0|aCOVID-19 vaccines|xGovernment policy|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body.
77508|tDirectives sur l'administration d'une dose supplémentaire de vaccins contre la COVID-19 au printemps 2024 pour les personnes exposées à un risque élevé de maladie sévère en raison de la COVID-19.|w(CaOODSP)9.931313
85640|qPDF|s561 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-176-1-2024-eng.pdf|zGuidance
85640|qPDF|sKB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-176-2-2024-eng.pdf|zSummary